← Leaderboards
Steven H Ferris
New York University School Of Medicine
$3,420,933
Attributed
$3,420,933
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$29,800,324 · 12
By mechanism
P30$29,782,014 · 4
M01$18,310 · 7
U01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Mary Sherman Mittelman$13,657,884
- Iman Osman$8,470,073
- Howard S Hochster$9,390,994
- Gabrielle Gold-Von Simson$641,359
- Livia B Wan$780,040
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAlzheimer'S DiseaseNeuroimagingHuman SubjectPsychosocialNeuropathologyData ManagementS DiseaseResearch PersonnelEarly DiagnosisResourcesEducational AspectsAdvisory CommitteesPilot ProjectsCollaborationsAging BrainProgramsUnited States National Institutes Of HealthClinical ResearchFundingResearch Project GrantsSamplingData SetClinical Trials
Grant awards (43)
Core A. Administrative Core$313,573
P30 · FY2018 · AG · contact PI
Data Management and Statistical Core$286,997
P30 · FY2018 · AG · contact PI
Core A. Administrative Core$355,754
P30 · FY2017 · AG · contact PI
Data Management and Statistical Core$286,997
P30 · FY2017 · AG · contact PI
Core A. Administrative Core$313,572
P30 · FY2015 · AG · contact PI
Data Management and Statistical Core$286,997
P30 · FY2015 · AG · contact PI
Alzheimer's Disease Core Center$1,828,568
P30 · FY2014 · AG · contact PI
ADMINISTRATIVE CORE$304,835
P30 · FY2014 · AG · contact PI
Alzheimer's Disease Core Center$1,704,120
P30 · FY2013 · AG · contact PI
Alzheimer's Disease Core Center$391,976
P30 · FY2013 · AG · contact PI
ADMINISTRATIVE CORE$286,887
P30 · FY2013 · AG · contact PI
Alzheimer's Disease Core Center$1,830,027
P30 · FY2012 · AG · contact PI
ADMINISTRATIVE CORE$323,641
P30 · FY2012 · AG · contact PI
Alzheimer's Disease Core Center$1,828,153
P30 · FY2011 · AG · contact PI
ADMINISTRATIVE CORE$324,690
P30 · FY2011 · AG · contact PI
Alzheimer's Disease Core Center$1,861,978
P30 · FY2010 · AG · contact PI
ADMINISTRATIVE CORE$318,680
P30 · FY2010 · AG · contact PI
Alzheimer's Disease Core Center$1,777,309
P30 · FY2009 · AG · contact PI
Alzheimer's Disease Core Center$1,731,400
P30 · FY2008 · AG · contact PI
Alzheimer's Disease Core Center$163,608
P30 · FY2008 · AG · contact PI
Alzheimer's Disease Core Center$1,720,888
P30 · FY2007 · AG · contact PI
Alzheimer's Disease Core Center$1,726,219
P30 · FY2006 · AG · contact PI
A TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE$936
M01 · FY2006 · RR · contact PI
HIGH DOSE SUPPLEMENTS TO TREAT ALZHEIMER'S DISEASE$936
M01 · FY2006 · RR · contact PI
Alzheimer's Disease Core Center$1,663,626
P30 · FY2005 · AG
Alzheimer's Disease Core Center$38,640
P30 · FY2005 · AG
A TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE$4,774
M01 · FY2005 · RR
HIGH DOSE SUPPLEMENTS TO TREAT ALZHEIMER'S DISEASE$3,820
M01 · FY2005 · RR
ALZHEIMER'S DISEASE DIAGNOSIS: LEUKOCYTE MULTIGENE SIGNATURES$477
M01 · FY2005 · RR
ALZHEIMERS DISEASE CORE CENTER$1,684,543
P30 · FY2004 · AG
High Dose Supplements to Treat Alzheimer's Disease$3,811
M01 · FY2004 · RR
Alzheimer's Disease Diagnosis: Leukocyte Multigene Signatures$2,540
M01 · FY2004 · RR
ALZHEIMERS DISEASE CORE CENTER$2,000
P30 · FY2004 · AG
Assessment Measures for AD Primary Prevention Trials$762
M01 · FY2004 · RR
Vitamin E and Donepezil in Mild Cognitive Impairment and Alzheimer's DiseaseV$254
M01 · FY2004 · RR
ALZHEIMERS DISEASE CORE CENTER$1,644,502
P30 · FY2003 · AG
ALZHEIMERS DISEASE CORE CENTER$1,610,002
P30 · FY2002 · AG
ASSESSMENT MEASURES FOR AD PRIMARY PREVENTION TRIALS$0
U01 · FY2002 · AG
ASSESSMENT MEASURES FOR AD PRIMARY PREVENTION TRIALS$0
U01 · FY2002 · AG
ALZHEIMERS DISEASE CORE CENTER$1,572,697
P30 · FY2001 · AG
ASSESSMENT MEASURES FOR AD PRIMARY PREVENTION TRIALS$0
U01 · FY2001 · AG
ALZHEIMERS DISEASE CORE CENTER$1,551,028
P30 · FY2000 · AG
ALZHEIMERS DISEASE CORE CENTER$48,107
P30 · FY2000 · AG